Human monoclonal antibodies derived from B cells of patients infected from the early SARS-CoV-2 variants and from vaccinated individuals are rapidly losing their efficacy with the emergence of new ...

Researchers led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have developed antibodies that can simultaneously bind to two different antigens, targeting multiple ...

In a recent article published in the Science Translational Medicine Journal, researchers longitudinally isolated immensely potent monoclonal antibodies (mAbs) from macaques vaccinated with monovalent ...

Antibodies have been identified that neutralize Omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

CHICAGO (Reuters) - Aerium Therapeutics, a venture-backed startup, on Tuesday announced industry veteran Rajeev Venkayya will lead the company and released data that showed its two experimental ...

The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...

ST. LOUIS — Antibodies generated by Pfizer’s COVID-19 vaccine are effective at blocking the delta variant – more so than at least one other variant – according to a new study from researchers at ...

The spike protein of BA.2.86 — a subvariant of Omicron — has a large number of mutations, and binds to its receptor in host cells with high affinity. Despite these characteristics, BA.2.86 is no more ...

Viral variation has proved to be a critical weak point in our approach to medical solutions for controlling Covid-19. Over the last two and a half years, we've seen successive waves of reinfection by ...

Scientists have reported good news on the pandemic preparedness front: A cocktail of four manufactured antibodies is effective at neutralizing a virus from the Henipavirus family, a group of pathogens ...

Llama antibodies could be a potent force in preventing infections from contagious COVID-19 variants, a biomedical company has claimed. Researchers from the VIB-UGent Center for Medical Biotechnology ...